CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 237 filers reported holding CLOVIS ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $11,240,000 | -30.4% | 382,705 | +7.8% | 0.41% | -32.2% |
| Q2 2018 | $16,143,000 | +47.7% | 355,033 | +71.6% | 0.61% | +39.0% |
| Q1 2018 | $10,926,000 | -38.2% | 206,926 | -20.4% | 0.44% | -35.7% |
| Q4 2017 | $17,685,000 | -35.6% | 260,069 | -22.0% | 0.68% | -39.1% |
| Q3 2017 | $27,472,000 | +15.5% | 333,396 | +31.2% | 1.12% | +12.5% |
| Q2 2017 | $23,784,000 | +64.2% | 254,024 | +11.6% | 0.99% | +67.1% |
| Q1 2017 | $14,489,000 | – | 227,571 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |